Report Thumbnail
Product Code LP0914214527TB
Published Date 2026/5/28
English85 PagesGlobal

Global Endothelial Keratoplasty (EK) Market Growth (Status and Outlook) 2026-2032 ‐ MedicalDevice / MedTech Market


Report Thumbnail
Product Code LP0914214527TB◆An updated version may be available. We will check for you.
Published Date 2026/5/28
English 85 PagesGlobal

Global Endothelial Keratoplasty (EK) Market Growth (Status and Outlook) 2026-2032 ‐ MedicalDevice / MedTech Market



Abstract

This report provides a comprehensive analysis of the global Endothelial Keratoplasty (EK) market, which is projected to experience significant growth through 2032. The study examines key cornea transplant techniques, specifically DSEK and DMEK, and segments the market by application and geography, including major regions like the Americas, APAC, and Europe. By evaluating competitive landscapes, emerging trends, and key industry players, the report offers strategic insights into the drivers shaping the future trajectory of this specialized ophthalmic sector.

Related Questions

US$ 156 million in 2025

19.4% from 2026 to 2032

Mayo Clinic, Cellusion, LaserVision, Precise Bio, Altomed, CorneaGen


Summary

Market Overview

Global Market Forecast

The global Endothelial Keratoplasty (EK) market size is predicted to grow from US$ 156 million in 2025 to US$ 529 million in 2032, representing a compound annual growth rate (CAGR) of 19.4% from 2026 to 2032.

Regional Market Outlook

  • United States: The market for Endothelial Keratoplasty (EK) in the United States is estimated to experience steady growth from 2025 through 2032.
  • China: The market for Endothelial Keratoplasty (EK) in China is estimated to undergo expansion between 2025 and 2032.
  • Europe: The market for Endothelial Keratoplasty (EK) in Europe is estimated to increase over the forecast period from 2025 to 2032.

Product Definition and Clinical Application

Endothelial keratoplasty (EK) is a cornea transplant technique that serves as the preferred method to restore vision when the inner cell layer of the cornea ceases to function properly. This dysfunction may be caused by:

  • Fuchs’ dystrophy
  • Bullous keratopathy
  • Iridocorneal endothelial (ICE) syndrome
  • Other endothelial disorders

EK is characterized by its ability to selectively replace only the diseased layer of the cornea while leaving healthy areas intact.

Report Scope and Methodology

Research Objectives

LPI (LP Information)'s newest research report, titled “Endothelial Keratoplasty (EK) Industry Forecast,” provides a comprehensive analysis of the global Endothelial Keratoplasty (EK) landscape. The report achieves the following:

  • Sales Analysis: Reviews total world Endothelial Keratoplasty (EK) sales in 2025 and examines past sales data.
  • Projected Sales: Provides a detailed analysis in US$ millions of projected Endothelial Keratoplasty (EK) sales for the period of 2026 through 2032, broken down by region, market sector, and sub-sector.
  • Market Dynamics: Highlights key trends related to product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
  • Competitive Intelligence: Analyzes the strategies of leading global companies, focusing on their EK portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating market.
  • Strategic Insights: Evaluates key market trends, drivers, and affecting factors shaping the global outlook to highlight emerging pockets of opportunity.

Methodology

The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, offering a highly nuanced view of the current state and future trajectory of the global Endothelial Keratoplasty (EK) industry.

Market Segmentation

By Type

  • Descemet's Stripping Endothelial Keratoplasty (DSEK)
  • Descemet's Membrane Endothelial Keratosplaty (DMEK)

By Application

  • Adults
  • Children

By Region

  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Competitive Landscape

Key Market Trends

The report examines market shares and growth opportunities across product types, applications, key players, and key regions/countries. In terms of revenue, the global two largest companies are expected to hold a significant portion of the market share in 2025.

Key Players

The following companies have been profiled based on inputs gathered from primary experts and an analysis of their coverage, product portfolio, and market penetration:

  • Mayo Clinic
  • Cellusion
  • LaserVision
  • Precise Bio
  • Altomed
  • CorneaGen

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Endothelial Keratoplasty (EK) Market Size (2021-2032)
      • 2.1.2 Endothelial Keratoplasty (EK) Market Size CAGR by Region (2021 VS 2025 VS 2032)
      • 2.1.3 World Current & Future Analysis for Endothelial Keratoplasty (EK) by Country/Region (2021, 2025 & 2032)
    • 2.2 Endothelial Keratoplasty (EK) Segment by Type
      • 2.2.1 Descemet's Stripping Endothelial Keratoplasty (DSEK)
      • 2.2.2 Descemet's Membrane Endothelial Keratosplaty (DMEK)
      • 2.2.3 Endothelial Keratoplasty (EK) Market Size by Type
        • 2.2.3.1 Endothelial Keratoplasty (EK) Market Size CAGR by Type (2021 VS 2025 VS 2032)
        • 2.2.3.2 Global Endothelial Keratoplasty (EK) Market Size Market Share by Type (2021-2026)
    • 2.3 Endothelial Keratoplasty (EK) Segment by Application
      • 2.3.1 Adults
      • 2.3.2 Children
      • 2.3.3 Endothelial Keratoplasty (EK) Market Size by Application
        • 2.3.3.1 Endothelial Keratoplasty (EK) Market Size CAGR by Application (2021 VS 2025 VS 2032)
        • 2.3.3.2 Global Endothelial Keratoplasty (EK) Market Size Market Share by Application (2021-2026)
  • 3 Endothelial Keratoplasty (EK) Market Size by Player

    • 3.1 Endothelial Keratoplasty (EK) Market Size Market Share by Player
      • 3.1.1 Global Endothelial Keratoplasty (EK) Revenue by Player (2021-2026)
      • 3.1.2 Global Endothelial Keratoplasty (EK) Revenue Market Share by Player (2021-2026)
    • 3.2 Global Endothelial Keratoplasty (EK) Key Players Head office and Products Offered
    • 3.3 Market Concentration Rate Analysis
      • 3.3.1 Competition Landscape Analysis
      • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    • 3.4 New Products and Potential Entrants
    • 3.5 Mergers & Acquisitions, Expansion
  • 4 Endothelial Keratoplasty (EK) by Region

    • 4.1 Endothelial Keratoplasty (EK) Market Size by Region (2021-2026)
    • 4.2 Global Endothelial Keratoplasty (EK) Annual Revenue by Country/Region (2021-2026)
    • 4.3 Americas Endothelial Keratoplasty (EK) Market Size Growth (2021-2026)
    • 4.4 APAC Endothelial Keratoplasty (EK) Market Size Growth (2021-2026)
    • 4.5 Europe Endothelial Keratoplasty (EK) Market Size Growth (2021-2026)
    • 4.6 Middle East & Africa Endothelial Keratoplasty (EK) Market Size Growth (2021-2026)
  • 5 Americas

    • 5.1 Americas Endothelial Keratoplasty (EK) Market Size by Country (2021-2026)
    • 5.2 Americas Endothelial Keratoplasty (EK) Market Size by Type (2021-2026)
    • 5.3 Americas Endothelial Keratoplasty (EK) Market Size by Application (2021-2026)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Endothelial Keratoplasty (EK) Market Size by Region (2021-2026)
    • 6.2 APAC Endothelial Keratoplasty (EK) Market Size by Type (2021-2026)
    • 6.3 APAC Endothelial Keratoplasty (EK) Market Size by Application (2021-2026)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
  • 7 Europe

    • 7.1 Europe Endothelial Keratoplasty (EK) Market Size by Country (2021-2026)
    • 7.2 Europe Endothelial Keratoplasty (EK) Market Size by Type (2021-2026)
    • 7.3 Europe Endothelial Keratoplasty (EK) Market Size by Application (2021-2026)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Endothelial Keratoplasty (EK) by Region (2021-2026)
    • 8.2 Middle East & Africa Endothelial Keratoplasty (EK) Market Size by Type (2021-2026)
    • 8.3 Middle East & Africa Endothelial Keratoplasty (EK) Market Size by Application (2021-2026)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Global Endothelial Keratoplasty (EK) Market Forecast

    • 10.1 Global Endothelial Keratoplasty (EK) Forecast by Region (2027-2032)
      • 10.1.1 Global Endothelial Keratoplasty (EK) Forecast by Region (2027-2032)
      • 10.1.2 Americas Endothelial Keratoplasty (EK) Forecast
      • 10.1.3 APAC Endothelial Keratoplasty (EK) Forecast
      • 10.1.4 Europe Endothelial Keratoplasty (EK) Forecast
      • 10.1.5 Middle East & Africa Endothelial Keratoplasty (EK) Forecast
    • 10.2 Americas Endothelial Keratoplasty (EK) Forecast by Country (2027-2032)
      • 10.2.1 United States Market Endothelial Keratoplasty (EK) Forecast
      • 10.2.2 Canada Market Endothelial Keratoplasty (EK) Forecast
      • 10.2.3 Mexico Market Endothelial Keratoplasty (EK) Forecast
      • 10.2.4 Brazil Market Endothelial Keratoplasty (EK) Forecast
    • 10.3 APAC Endothelial Keratoplasty (EK) Forecast by Region (2027-2032)
      • 10.3.1 China Endothelial Keratoplasty (EK) Market Forecast
      • 10.3.2 Japan Market Endothelial Keratoplasty (EK) Forecast
      • 10.3.3 Korea Market Endothelial Keratoplasty (EK) Forecast
      • 10.3.4 Southeast Asia Market Endothelial Keratoplasty (EK) Forecast
      • 10.3.5 India Market Endothelial Keratoplasty (EK) Forecast
      • 10.3.6 Australia Market Endothelial Keratoplasty (EK) Forecast
    • 10.4 Europe Endothelial Keratoplasty (EK) Forecast by Country (2027-2032)
      • 10.4.1 Germany Market Endothelial Keratoplasty (EK) Forecast
      • 10.4.2 France Market Endothelial Keratoplasty (EK) Forecast
      • 10.4.3 UK Market Endothelial Keratoplasty (EK) Forecast
      • 10.4.4 Italy Market Endothelial Keratoplasty (EK) Forecast
      • 10.4.5 Russia Market Endothelial Keratoplasty (EK) Forecast
    • 10.5 Middle East & Africa Endothelial Keratoplasty (EK) Forecast by Region (2027-2032)
      • 10.5.1 Egypt Market Endothelial Keratoplasty (EK) Forecast
      • 10.5.2 South Africa Market Endothelial Keratoplasty (EK) Forecast
      • 10.5.3 Israel Market Endothelial Keratoplasty (EK) Forecast
      • 10.5.4 Turkey Market Endothelial Keratoplasty (EK) Forecast
    • 10.6 Global Endothelial Keratoplasty (EK) Forecast by Type (2027-2032)
    • 10.7 Global Endothelial Keratoplasty (EK) Forecast by Application (2027-2032)
      • 10.7.1 GCC Countries Market Endothelial Keratoplasty (EK) Forecast
  • 11 Key Players Analysis

    • 11.1 Mayo Clinic
      • 11.1.1 Mayo Clinic Company Information
      • 11.1.2 Mayo Clinic Endothelial Keratoplasty (EK) Product Offered
      • 11.1.3 Mayo Clinic Endothelial Keratoplasty (EK) Revenue, Gross Margin and Market Share (2021-2026)
      • 11.1.4 Mayo Clinic Main Business Overview
      • 11.1.5 Mayo Clinic Latest Developments
    • 11.2 Cellusion
      • 11.2.1 Cellusion Company Information
      • 11.2.2 Cellusion Endothelial Keratoplasty (EK) Product Offered
      • 11.2.3 Cellusion Endothelial Keratoplasty (EK) Revenue, Gross Margin and Market Share (2021-2026)
      • 11.2.4 Cellusion Main Business Overview
      • 11.2.5 Cellusion Latest Developments
    • 11.3 LaserVision
      • 11.3.1 LaserVision Company Information
      • 11.3.2 LaserVision Endothelial Keratoplasty (EK) Product Offered
      • 11.3.3 LaserVision Endothelial Keratoplasty (EK) Revenue, Gross Margin and Market Share (2021-2026)
      • 11.3.4 LaserVision Main Business Overview
      • 11.3.5 LaserVision Latest Developments
    • 11.4 Precise Bio
      • 11.4.1 Precise Bio Company Information
      • 11.4.2 Precise Bio Endothelial Keratoplasty (EK) Product Offered
      • 11.4.3 Precise Bio Endothelial Keratoplasty (EK) Revenue, Gross Margin and Market Share (2021-2026)
      • 11.4.4 Precise Bio Main Business Overview
      • 11.4.5 Precise Bio Latest Developments
    • 11.5 Altomed
      • 11.5.1 Altomed Company Information
      • 11.5.2 Altomed Endothelial Keratoplasty (EK) Product Offered
      • 11.5.3 Altomed Endothelial Keratoplasty (EK) Revenue, Gross Margin and Market Share (2021-2026)
      • 11.5.4 Altomed Main Business Overview
      • 11.5.5 Altomed Latest Developments
    • 11.6 CorneaGen
      • 11.6.1 CorneaGen Company Information
      • 11.6.2 CorneaGen Endothelial Keratoplasty (EK) Product Offered
      • 11.6.3 CorneaGen Endothelial Keratoplasty (EK) Revenue, Gross Margin and Market Share (2021-2026)
      • 11.6.4 CorneaGen Main Business Overview
      • 11.6.5 CorneaGen Latest Developments
  • 12 Research Findings and Conclusion

USD 7,320 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.